Multimodal tretment of intracranial aneurysm

Abstract

Aneurysmal subarachnoid hemorrhage (SAH), despite improvements in imagistic and medical treatment, is still a serious disease with high rates of case mortality and morbidity (40%). Technical planning and therapy options of patients with aneurismal SAH have changed during the angioCT and 3D angiography era, and long-term outcome has significantly improved during the past few decades. However, the outcome is still determined mainly by specialist experience and severity of initial bleeding or early rebleeding.